Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 5 of about 5 for Ipsen, Inc
Company Exchange Symbol Last price Quote change Market cap
Exelixis, Inc. NASDAQ EXEL 8.71 +0.03 (0.35%) 2.01B
Exelixis, Inc. is a biopharmaceutical company. The Company is engaged in developing small molecule therapies for the treatment of cancer.
Ipsen Biopharmaceuticals, Inc. Private
Hey, cut Tercica some slack -- it's feeling a bit hormonal. The company's drug therapies focus on the treatment of growth disorders.
Lexicon Pharmaceuticals, Inc. NASDAQ LXRX 15.84 +0.09 (0.57%) 1.68B
Lexicon Pharmaceuticals, Inc. (Lexicon) is a biopharmaceutical company. The Company focuses on the development of treatments for human disease.
EXELIXIS INC. DL-,01 FRA EX9 7.95 +0.03 (0.37%)
EXELIXIS INC. DL-,01 ETR EX9 0.0000